Products in Development

At INSYS, we're focused on developing and commercializing innovative drugs and novel drug delivery systems that improve the quality of patients' lives.

Through our proprietary spray technology and our capability to develop pharmaceutical cannabinoids, we have improved the properties of existing molecules. What does this mean for patients? With each product, we make available better solutions that can provide relief around the conditions that burden their lives.

Our product pipeline is aimed at addressing conditions with unmet medical needs, such as refractory pediatric epilepsy (including childhood absence epilepsy and infantile spasms), the genetic disorder Prader-Willi syndrome, anorexia-associated weight loss in cancer patients, agitation in Alzheimer's disease, migraine, anaphylaxis (severe allergic reaction), acute pain, opioid dependence and reversal of opioid-induced respiratory depression.

hello
Drug Candidate Disease State Status
Cannabidiol
oral solution
(i) Childhood absence epilepsy
(ii) Infantile spasm
(iii) Prader-Willi syndrome
Dronabinol
inhalation
(i) Anorexia in cancer patients
(ii) Agitation in Alzheimer’s disease
Buprenorphine
sublingual spray
Moderate-to-severe
acute pain
Buprenorphine / Naloxone sublingual spray Opioid dependence
Epinephrine
nasal spray
Anaphylactic reaction
Naloxone
nasal spray
Opioid overdose
Rizatriptan
nasal spray
Migraine  

CANNABINOIDS

  • Cannabidiol
    oral solution
    Disease State
    (i) Childhood absence epilepsy
    Phase

    Disease State
    (ii) Infantile spasm
    Phase

    Disease State
    (iii) Prader-Willi syndrome
    Phase
  • Dronabinol
    inhalation
    Disease State
    (i) Anorexia in cancer patients
    Phase

    Disease State
    (ii) Agitation in Alzheimer’s disease
    Phase

SPRAYS

Approved Products

To reach patients whose needs are unmet by current pharmaceutical offerings, we produce innovative drugs and drug delivery systems. See what is approved.

 

Approved Products

To reach patients whose needs are unmet by current pharmaceutical offerings, we produce innovative drugs and drug delivery systems. See what is approved.